Cancer Research Tempus

Eric Lefkofsky VS The World

What Eric Lefkofsky’s Tempus AI-powered personalized medicine company lacks in flashy marketing, it more than makes up for with results. In a recent article from Bloomberg News, the CEO of Tempus shared that their focus is on “those disease areas that are the most deadly.” With experience spanning over 20 years in diagnosing different types of cancer and operating one of Chicago’s largest private equity firms (Lefkosky Group), he understands what patients need to live healthier lives. 


Tempus has grown quickly since its founding by branching out into other programs including mental health, infectious diseases such as HIV/AIDS or hepatitis C; cardiovascular conditions like heart attacks or high blood pressure; cardiology treatments. As a new company led by Eric Lefkofsky, Tempus is looking to make a change in the way pharmaceutical companies target drugs. The organization strives to team up with other groups who have similar ambitions in figuring out challenges within the field of life science.


Through their advanced technology and vast database of healthcare data, they are able to help pharma developers find targets for specific ailments with pinpoint accuracy. The way Tempus unveiled Eric Lefkosky’s idea is with a new generation of smart devices, a portable device that can go anywhere. The Tempus ONE is similar to Amazon Alexa or Google Home but designed specifically for oncologists. Eric Lefkofsky explains that doctors will be able to not only get real-time information about clinical insights and data from this device, they’ll also have access within seconds if an order has been completed by their nurse at home too!

Keep on reading about Eric Lefkofsky and Tempus pharmaceutical firm